Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04522193

Dumping Syndrome and Esophageal Atresia

Physiopathology of Dumping Syndrome in Esophageal Atresia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
2 Months – 3 Months
Healthy volunteers
Not accepted

Summary

Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection difficult to diagnose, because it only occurs after meals and can be inconstantly present. To date, their is only symptomatic treatment for DS. This study aims to understand its pathological mechanisms so as to better treat it and avoid its consequences. Oesophageal atresia patients enrolled in this study will benefit from a continuous glycemic monitoring, a continuous cardiac monitoring, and an a gastric emptying scintigraphy at the age of 3 months

Conditions

Interventions

TypeNameDescription
DEVICEGlycemic HolterContinuous glycaemia monitoring,
RADIATIONgastric emptying scintigraphyFasting administration of a Technecium-labelled milk bottle and quantification of the remaining radioactivity by a camera every 30 minutes for 4 hours.
DEVICEHolter ECGcontinuous cardiac monitoring

Timeline

Start date
2024-02-23
Primary completion
2026-11-01
Completion
2026-11-01
First posted
2020-08-21
Last updated
2025-12-23

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04522193. Inclusion in this directory is not an endorsement.